Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial

References

Page 1

	Year	Citations
WHO Handbook for Reporting Results of Cancer Treatment M K Palmer British Journal of Cancer MedicineCancer ManagementOutcomes ResearchCancer TreatmentOncology	1982	2.2K
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. M L Slevin, Peter Clark, S P Joel, Journal of Clinical Oncology MedicineChemotherapyPharmacologyMetronomic TherapySmall-cell Lung Cancer	1989	464
An overview of prognostic factors in small cell lung cancer J Peto British Journal of Cancer Prognostic FactorsMedicineMultiple Pulmonary NodulePathologyBronchial Neoplasm	1990	205
Bioavailability of low-dose oral etoposide. Kenneth R. Hande, Mary G. Krozely, F. Anthony Greco, Journal of Clinical Oncology	1993	144
Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B. Antonius A. Miller, James E. Herndon, Donna Hollis, Journal of Clinical Oncology	1995	106
Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. British Journal of Cancer Radiation MedicineRadiation TherapyMedicineSmall-cell CarcinomaBronchial Neoplasm	1979	76
Variable bioavailability following repeated oral doses of etoposide V.J. Harvey, M L Slevin, S.P. Joel, European Journal of Cancer and Clinical Oncology Pharmacological StudyMedicineVariable BioavailabilityClinical PharmacologyToxicology	1985	64
Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis NM Bleehen, DJ Girling, Penelope Hopwood, British Journal of Cancer OncologyIntensive Two-drug ChemotherapyMedicineFour-drug VsClinical Trials	1996	55
The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer. Peter Clark, B. Cottier PubMed	1992	50
Cancer and Its Management M. Tattersall Pathology MedicineCancer ManagementPathologyOncologyCancer Research	1987	21

Page 1